Stocktoria
THERMO FISHER SCIENTIFIC INC. TMO
THERMO FISHER SCIENTIFIC INC. (TMO) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 0.33% (safety: safe). FY2025 revenue was $44.6B at a 15.0% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-07-27 | Piper Sandler | Neutral (main) |
| 2026-07-27 | Morgan Stanley | Overweight (main) |
| 2026-07-24 | RBC Capital | Sector Perform (main) |
| 2026-07-24 | Barclays | Overweight (main) |
| 2026-07-06 | Evercore ISI Group | Outperform (main) |
| 2026-06-11 | Piper Sandler | Neutral (init) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Forward estimates · earnings calendar →
Consensus analyst estimates and scheduled dates — forward-looking, may change.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.123 |
| Retained earnings / assets | 0.536 |
| EBIT / assets | 0.07 |
| Equity / liabilities | 0.938 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC. | 5/9 | 4.01 | 28.4 | +3.9% |
| ROK | ROCKWELL AUTOMATION, INC | 7/9 | 3.39 | 61.1 | +0.9% |
| TRMB | TRIMBLE INC. | 4/9 | 3.47 | 27.9 | -2.6% |
| ONTO | ONTO INNOVATION INC. | 3/9 | 12.57 | 117.8 | +1.8% |
| GEOS | GEOSPACE TECHNOLOGIES CORP | 1/9 | 8.01 | — | -18.3% |
| OWLT | Owlet, Inc. | 4/9 | -9.08 | — | +35.4% |
| MASS | 908 Devices Inc. | 3/9 | 1.84 | 17 | +17.7% |
About THERMO FISHER SCIENTIFIC INC.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
FAQ
Is TMO financially healthy?
THERMO FISHER SCIENTIFIC INC.'s Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does TMO pay a dividend, and is it safe?
Yes. THERMO FISHER SCIENTIFIC INC. pays a dividend yielding about 0.33% with a 9.5% payout ratio, rated “safe” for safety.
How profitable is TMO?
In FY2025, THERMO FISHER SCIENTIFIC INC. had a net margin of 15.0% and a return on equity of 12.6%.
Is TMO overvalued or undervalued?
THERMO FISHER SCIENTIFIC INC. trades at about 34.0× trailing earnings — near its 10-year norm (10-year range 29.9×–40.1×, median 33.9×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for TMO?
The average Wall-Street price target for THERMO FISHER SCIENTIFIC INC. is $631.42, about 4.7% above the recent price, from 26 analysts (consensus: buy).
Is TMO a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on THERMO FISHER SCIENTIFIC INC.: a Piotroski F-score of 5/9, an Altman Z″ in the safe zone, a P/E of about 28.4×, a dividend yield of 0.33%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.